Apollomics Statistics
Total Valuation
Apollomics has a market cap or net worth of $34.92 million. The enterprise value is $26.10 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apollomics has 2.15 million shares outstanding. The number of shares has increased by 37.10% in one year.
| Current Share Class | 2.15M |
| Shares Outstanding | 2.15M |
| Shares Change (YoY) | +37.10% |
| Shares Change (QoQ) | +17.62% |
| Owned by Insiders (%) | 50.87% |
| Owned by Institutions (%) | 0.00% |
| Float | 1.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.82 |
| Forward PS | n/a |
| PB Ratio | 3.69 |
| P/TBV Ratio | 11.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 131.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.39 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -229.76 |
Financial Efficiency
Return on equity (ROE) is -233.67% and return on invested capital (ROIC) is -99.39%.
| Return on Equity (ROE) | -233.67% |
| Return on Assets (ROA) | -75.07% |
| Return on Invested Capital (ROIC) | -99.39% |
| Return on Capital Employed (ROCE) | -721.65% |
| Revenue Per Employee | $15,231 |
| Profits Per Employee | -$4.14M |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Apollomics has paid $259,000 in taxes.
| Income Tax | 259,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.99% in the last 52 weeks. The beta is 1.80, so Apollomics's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | +55.99% |
| 50-Day Moving Average | 15.70 |
| 200-Day Moving Average | 8.90 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 35,993 |
Short Selling Information
The latest short interest is 23,413, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 23,413 |
| Short Previous Month | 15,723 |
| Short % of Shares Out | 1.09% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, Apollomics had revenue of $198,000 and -$53.86 million in losses. Loss per share was -$52.80.
| Revenue | 198,000 |
| Gross Profit | 198,000 |
| Operating Income | -41.13M |
| Pretax Income | -53.60M |
| Net Income | -53.86M |
| EBITDA | -41.06M |
| EBIT | -41.13M |
| Loss Per Share | -$52.80 |
Full Income StatementBalance Sheet
The company has $9.78 million in cash and $966,000 in debt, giving a net cash position of $8.81 million or $4.11 per share.
| Cash & Cash Equivalents | 9.78M |
| Total Debt | 966,000 |
| Net Cash | 8.81M |
| Net Cash Per Share | $4.11 |
| Equity (Book Value) | 4.86M |
| Book Value Per Share | 4.41 |
| Working Capital | 2.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.74 million and capital expenditures -$24,000, giving a free cash flow of -$28.77 million.
| Operating Cash Flow | -28.74M |
| Capital Expenditures | -24,000 |
| Free Cash Flow | -28.77M |
| FCF Per Share | -$13.40 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -20,771.21% |
| Pretax Margin | -27,070.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |